Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01086774

Enrollment

Registered

2010-03-15

Start date

2010-07-31

Completion date

Unknown

Last updated

2012-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Keywords

Dry eye, Tear Film Stability

Brief summary

Evaluation of the optical effects of Systane Ultra

Interventions

OTHERSystane Ultra Lubricant Eye Drops

Single drop in both eyes

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Age 18 years or more. 2. Subjects must have Tear Break Up Time (TBUT) \< 5 seconds 3. Subjects must have a maximum blink interval (MBI) \< 10 seconds 4. Subjects must be willing to comply with all study requirements. 5. Subjects must understand, sign and be given a copy of the written Informed Consent form.

Exclusion criteria

1. Subjects for whom both eyes do not meet all inclusion criteria and either eye meets

Design outcomes

Primary

Measure	Time frame
Improvement in maximum blink interval (MBI)	1 day

Secondary

Measure	Time frame
Tear film stability and contrast sensitivity	1 day

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026